TGFβ signaling is dysregulated in glioblastoma, and this aberrant signaling contributes to tumor progression through multiple biological processes, including promoting tumor cell proliferation, enhancing tumor invasion, suppressing anti-tumor immune response, maintaining self-renewal capacity of glioma stem cells and activating angiogenesis [reviewed in Ref. The gene discussed is TGFB1; the disease is central nervous system cancer.